Position in TAK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,316,607
-$738,847 QoQ
Shares Held
206,900
-5.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#53
of 376 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MANNING & NAPIER ADVISORS LLC holds $28,794,500 across 9 Drug Manufacturers - Specialty & Generic names. TAK ranks #2 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,425,546 | $22,637,670 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
206,900 | $3,316,607 | |
| 3 | HLN |
Haleon plc
|
300,561 | $2,804,234 | |
| 4 | ZTS |
Zoetis Inc.
|
239 | $17,174 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
55 | $9,269 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
7 | $3,792 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
86 | $2,913 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
38 | $1,767 |
All Filings in TAK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,316,607 | 206,900 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,055,454 | 218,977 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,363,183 | 215,727 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,315,052 | 226,438 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $3,791,425 | 245,241 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,424,167 | 297,523 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $4,030,481 | 304,417 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $4,521,121 | 317,941 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $4,097,968 | 316,690 | Shares | Sole | 2024-07-11 | |
| No filing history on record for this holder in this stock. | ||||||